Medtronic stock was down less than 1 percent Wednesday afternoon ... Other …
Boston Scientific, Medtronic, Teleflex Incorporated, Stryker Corporation, CooperSurgical, ConMed Corporation. To ask a professional report sample or make an order, please email to tinaning@qyresearch.com or browse our detailed product …
Boston Scientific Corporation (NYSE:BSX) stock, even after its recent rally, looks like a steal after a $600 million settlement last week put an era of extreme litigation risk firmly behind the medical device-maker. Despite sitting at 7 …
How about you, Holmes, what have you got? Holmes: This week I like Boston Scientific (NYSE:BSX). This stock’s dip over the last month is the sort of set-up I like to see. From the chart below, you can see BSX is below its 50-day …
Boston Scientific Corporation BSX is scheduled to report second-quarter 2017 results before the opening bell on Jul 27. Last quarter, the company's earnings missed the Zacks Consensus Estimate by 3.3%. However, it posted an average …
NASDAQ2mon
HAMILTON, Bermuda - August 17, 2017-In a filing with the Bermuda Stock Exchange, Pallinghurst Resources Limited (the 'Company'; Ticker: PALLRES.BH), provided an update on issued share capital, directors' shareholdings and dealings by …
Boston Scientific Corp. (NYSE:BSX) garnered two upgrades and one downgrade from analysts this week, creating a roller-coaster effect in stock prices for the medical device giant. The company’s stock has been closing at higher and …
CHICAGO (Reuters) - Boston Scientific Corp. (BSX.N) shares dropped to their lowest level in 11 months as investors fretted over the growth prospects for the medical device maker. The company, whose shares were off as much as 10.9 …
Despite that reassurance, stock analysts with Leerink Securities wrote Thursday that the deal to acquire Symetis raises at least some concern about Boston Scientific’s confidence that Lotus will return to the market and be commercially viable.
We at Insider Monkey ... stock. Remaining peers with similar optimism encompass Paul Marshall and Ian Wace’s Marshall Wace LLP, Ken Griffin’s Citadel Investment Group and Principal Global Investors’ Columbus Circle Investors. …